Stanford researchers have found that estrogen-only hormone therapy is associated with significantly lower Alzheimer’s pathology in the brains of over 21,000 women. This finding could reshape clinical guidance and alter the trajectory of Alzheimer’s for millions.

$101 million is racing to reverse aging. Meanwhile, a Yale professor wants to force everyone out at 70. Who's right?"

Your Top 5 Longevity News in 5 minutes or less.

THEME OF THE WEEK

Healthspan goes operational — from senior living boardrooms to primary care clinics to federal rulemaking, institutions are translating longevity science into actionable practice.

Your Top 5 Longevity News in 5 minutes or less.

THEME OF THE WEEK

AI accelerates workforce transformation while policy and institutional readiness for longer lives falls further behind — but one state proves that public infrastructure for longevity can be built.

Your weekly top 5 longevity news in less than 5 minutes

The data is in, and the verdict is clear: humanity is adding years but not health; the workforce math does not work without older workers, and the institutions that shape daily life — from state budgets to AI labs — must redesign for the 100-year life or risk irrelevance.

THEME OF THE WEEK
AI and longevity are converging to reshape who works, how long they work, and whether the systems meant to support longer lives can keep pace.

This week’s stories reveal a single throughline: the technologies accelerating workplace disruption are colliding with demographic realities that demand longer careers, larger safety nets, and fundamentally different approaches to financial security and cognitive health.

⭐ THIS WEEK'S HIGHLIGHT
A Forbes analysis by Ron Schmelzer exposed the uncomfortable precision of AI-driven job displacement this week. While headlines focused on Microsoft’s 4,800 job cuts, the deeper story lies in who is most vulnerable: Brookings data identifies 6.1 million U.S. workers who combine high AI exposure with low adaptive capacity — 86% of them women.

PwC’s AI Jobs Barometer shows that “seniorized” entry-level roles grew 35% since 2019, and Boston College researchers confirm that workers 55 and older in high-exposure occupations are seeing rising exits.

For anyone designing a 100-year life, this is the clearest signal yet that AI is not eliminating all jobs — it is surgically targeting the workers least equipped to adapt, and the policy response has not kept pace.

WEEK IN LONGEVITY SNAPSHOT
This week brought converging signals across workforce, financial, and health dimensions of the longevity challenge.

A USC Schaeffer Center study revealed that the true annual cost of dementia in the United States reaches $818 billion — nearly four times what health-system accounting captures — with 73% of spending invisible to the formal system.

A Schroders survey found that Americans now say they need $1.2 million to retire, yet only 30% believe they will reach even $1 million.

Fortune reported that more than 30% of eligible Microsoft employees accepted a voluntary buyout targeting workers whose age plus years of service total 70 or more.

And a UC San Diego randomized trial published in Nature Communications showed that semaglutide reduced the rate of biological aging by 9% — the first causal clinical evidence linking a GLP-1 drug to slower epigenetic aging.

Theme of the Week: As governments push retirement ages higher and economists convene to map the longevity economy, this week revealed that the harder question is not how many years we add — but who designs the systems that make longer working lives livable.

This week’s highlight: Germany’s proposal to raise its retirement age toward 70 drew sharp comparisons to the United States, thanks to a Forbes analysis by economist Teresa Ghilarducci. The key insight: Germany can raise the age because its workers have better jobs, stronger unions, and higher healthy life expectancy. In the U.S., where occupational protections are weaker and life expectancy gains have stalled for lower-wage workers, simply raising the retirement age amounts to a benefit cut dressed as reform. This distinction matters enormously for any leader thinking about the 100-year life — longevity policy without worker protection is incomplete policy.

Week in longevity snapshot: This week brought a convergence of academic, policy, and economic signals that the world is taking the longevity transition seriously — but unevenly. The University of Cambridge hosted leading economists on longevity and aging; MIT’s Joseph Coughlin framed America’s 250th anniversary as a longevity design challenge; and S&P Global data showed global employment declining even as output grew — raising urgent questions about who benefits from longer productive lives as labor markets tighten.

THEME OF THE WEEK
As governments and researchers invest in making longer lives healthier and more productive, AI disruption threatens to push older workers out of the workforce before those investments pay off — exposing the central tension of the 100-year life.

THIS WEEK’S HIGHLIGHT
Boston College’s Center for Retirement Research published the first rigorous empirical analysis showing that exposure to AI correlates with rising job exits among older workers. Using Current Population Survey data matched
with Tufts University’s AI Exposure Index, researcher Geoffrey Sanzenbacher found that computer programmers ages 55 and older saw a 25-percent increase in transitions out of work since ChatGPT’s launch — even as their jobs historically offered longer careers than less-exposed occupations. The finding directly challenges the assumption that longer worklives can offset retirement funding gaps, precisely as policymakers consider raising the Social Security retirement age. This study stands above the rest this week because it converts anecdotal
concern into hard evidence, giving workforce strategists and policy designers a data-driven reason to act.

WEEK IN LONGEVITY SNAPSHOT
This week laid bare a defining contradiction of the longevity economy: the systems designed to extend productive life are advancing in parallel with technologies that could shorten careers. The World Economic Forum quantified
a $6.4 trillion opportunity in low-tech healthspan investments, while Boston College researchers documented a measurable rise in AI-driven job exits among older workers. Meanwhile, Maryland codified the nation’s most comprehensive longevity strategy into state law, and the American Society on Aging explored why older workers face persistent discrimination despite historically low unemployment. Together, these developments frame the 100-year life not as a distant aspiration but as an urgent design challenge for policymakers, employers, and workers right now.

THEME OF THE WEEK

From molecular mechanisms to legislative mechanisms, this week revealed a convergence: the science of extending healthy years and the policy infrastructure to fund them are advancing on parallel tracks — and both demand urgency.

THIS WEEK'S HIGHLIGHT

A Cleveland research team published findings in the Proceedings of the National Academy of Sciences identifying KLF4, a protein in blood-brain barrier endothelial cells, as a critical molecular driver of age-related cognitive decline. This stands above the other stories because it transforms our understanding of brain aging from an inevitable process into a potentially modifiable one — opening a concrete therapeutic target for neuroprotection. For leaders planning around 100-year lives, the possibility of preserving cognitive function into advanced age changes every assumption about workforce capability, retirement timing, and the economics of longer lives.

WEEK IN LONGEVITY SNAPSHOT

This week reinforced that the 100-year life is no longer a theoretical construct — it is an active design challenge for researchers, policymakers, and institutions alike. Two major healthspan studies shifted the scientific conversation from merely extending life toward preserving the biological coordination that keeps us functional, while on Capitol Hill, competing bipartisan proposals signaled that Social Security reform has moved from abstract debate to concrete legislative action. Meanwhile, new evidence on gendered ageism reminded us that the workforce systems meant to support longer careers still carry deep structural biases that undermine half the population a full decade earlier than the other.

THEME OF THE WEEK

AI is splitting the labor market into two tracks -- and the workers who thrive will be those who pair human judgment with continuous reskilling, regardless of age.

WEEK IN LONGEVITY SNAPSHOT

This week revealed a labor market cleaving into two distinct paths under AI pressure. PwC's landmark analysis of one billion job ads confirmed that roles emphasizing human judgment are pulling away from those AI can democratize -- a divide with profound implications for older workers whose experience becomes a competitive asset. Meanwhile, the reskilling imperative intensified as Gartner warned that AI will break down millions of careers even as it creates net new roles. And at the margins of this workforce upheaval, new healthspan research from Leiden University and a sweeping meta-analysis on social isolation reminded us that the 100-year life demands not just economic redesign but deeper investment in the biological and social foundations of healthy aging.

THIS WEEK'S HIGHLIGHT

PwC's 2026 Global AI Jobs Barometer -- the largest study of its kind, spanning one billion job advertisements across 27 countries -- found that AI is forging a two-track labor market. Professionalised roles, where AI automates routine tasks and elevates the value of human judgment, creativity, and leadership, grow at twice the rate of democratised roles, where AI makes the work accessible to non-experts. Salary growth in professionalised roles outpaces democratised ones by 42%. For longevity leaders, this is the most consequential workforce signal of 2026: experienced workers who can exercise judgment, mentor teams, and navigate ambiguity hold exactly the skills AI rewards most.